IP Verse

Pegylated Drug-Linkers For Improved Ligand-Drug Conjugate Pharmacokinetics - EP3057585

The patent EP3057585 was granted to Seagen on Jul 22, 2020. The application was originally filed on Oct 14, 2014 under application number EP14853953A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP3057585

SEAGEN
Application Number
EP14853953A
Filing Date
Oct 14, 2014
Status
Granted And Under Opposition
Jun 19, 2020
Publication Date
Jul 22, 2020
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

EUROPEAN OPPOSITIONSApr 22, 2021BASSILADMISSIBLE

Patent Citations (20) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONUS4880935
DESCRIPTIONUS8257706
DESCRIPTIONWO2007085930
DESCRIPTIONWO2010091150
DESCRIPTIONWO2011023883
DESCRIPTIONWO2012112708
INTERNATIONAL-SEARCH-REPORTUS2010062008
INTERNATIONAL-SEARCH-REPORTUS2010260786
INTERNATIONAL-SEARCH-REPORTUS2012107332
INTERNATIONAL-SEARCH-REPORTUS2013309256
OPPOSITIONUS2012328555
OPPOSITIONUS2013338231
OPPOSITIONUS6214345
OPPOSITIONWO2007011968
OPPOSITIONWO2008034124
OPPOSITIONWO2008070593
OPPOSITIONWO2013173337
SEARCHUS2010062008
SEARCHWO2007011968
SEARCHWO2016046574

Non-Patent Literature (NPL) Citations (7) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference Text
OPPOSITION- Aaron D. Baldwin, Kiick Kristi L., "Tunable Degradation of Maleimide–Thiol Adducts in Reducing Environments", Bioconjugate Chemistry, US , (20111019), vol. 22, no. 10, doi:10.1021/bc200148v, ISSN 1043-1802, pages 1946 - 1953, XP055246194
OPPOSITION- WILDMAN S A, CRIPPEN G M, "PREDICTION OF PHYSICOCHEMICAL PARAMETERS BY ATOMIC CONTRIBUTIONS", JOURNAL OF CHEMICAL INFORMATION AND COMPUTER SCIENCES, US , (19990101), vol. 39, no. 05, doi:10.1021/ci990307l, ISSN 0095-2338, pages 868 - 873, XP001029973
OPPOSITION- QUILES et al., "Synthesis and Preliminary Biological Evaluation of High-Drug-Load Paclitaxel-Antibody Conjugates for Tumor-Targeted Chemotherapy", Journal of Medicinal Chemistry, (20100000), vol. 53, no. 2, pages 586 - 594, XP055127608
OPPOSITION- Shashwat S Banerjee; Aher Naval; Patil Rajesh; Khandare Jayant, "Poly(ethylene glycol)-Prodrug Conjugates: Concept, Design, and Applications", Journal of Drug Delivery, (20120101), vol. 22, no. 4, pages 1 - 17, XP055079947
OPPOSITION- Kevin J. Hamblett, Peter D. Senter, Dana F. Chace, Michael M. C. Sun, Joel Lenox, Charles G. Cerveny, Kim M. Kissler, Starr X. Bernhardt, Anastasia K. Kopcha, Roger F. Zabinski, Damon L. Meyer, and Joseph A. Francisco, "Effects of drug loading on the antitumor activity of a monoclonal antibody drug conjugate", Clinical Cancer Research, US, (20041015), vol. 10, no. 20, doi:10.1158/1078-0432.CCR-04-0789, ISSN 1078-0432, pages 7063 - 7070, XP002623986
OPPOSITION- Kahn C R, White M F, "The insulin receptor and the molecular mechanism of insulin action", The Journal of Clinical Investigation, GB , (19881001), vol. 82, no. 4, doi:10.1172/JCI113711, ISSN 0021-9738, pages 1151 - 1156, XP055958235
SEARCH- GREENWALD ET AL, "E ffective drug delivery by PEGylated drug conjugate", ADVANCED DRUG DELIVERY REVIEWS, (20020714), vol. 55, pages ^217 - 250, XP055364554 [A] 1 * the whole document *

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents